 |
|
|
Federal prosecutors in New York have decided to close the
investigation into how actor Heath Ledger acquired two powerful painkillers
that contributed to his fatal overdose, a law enforcement official announced on
Wednesday, as reported by the Associated Press.
Prosecutors in the U.S.
attorney’s office in Manhattan
had been running a Drug Enforcement Administration inquiry into whether the
drugs found in Ledger’s body were obtained without a legal prescription.
However, the prosecutors have abandoned the investigation “because they don’t
believe there’s a viable target,” the official informed the Associated Press on
condition of anonymity because no charges have been filed.
The decision follows recent reports that actress Mary-Kate
Olsen was requiring immunity before testifying about the shocking death of her
close friend. According to authorities, she was the first person called by the
masseuse who discovered the 28-year-old actor’s body in his Manhattan apartment.
The DEA had acquired a subpoena that would have constrained
Olsen to testify if the negotiations with her attorney had failed. Nevertheless,
the subpoena issued by a federal grand jury will not be enforced, the official
told the AP on Wednesday, although the case could still be resumed if evidence
of a crime comes to surface.
DEA investigators believe the painkillers found in Heath
Ledger’s system, oxycodone and hydrocodone, had been obtained through illegal
means. Other medications taken by “The Dark Knight” actor, including
anti-anxiety medication and sleeping pills, were prescribed legally by
physicians in California and Texas.
The masseuse found Ledger’s lifeless body on Jan. 22.
According to police officials, she spent nine minutes telephoning Mary-Kate
Olsen three times before dialing 911, then called the twin actress a fourth
time following the paramedics’ arrival. Sometime during the telephone calls,
Olsen, who was in California
at that time, sent her personal security guards to the apartment to help,
police said.
© 2007 - 2009 - eFluxMedia